The medicine is being assessed by agencies including the European Union regulator, but the community is divided on its efficacy and safety.

中文翻译：

---

英国限制批准阿尔茨海默病药物 Lecanemab 引发激烈争论


该药物正在接受欧盟监管机构等机构的评估，但业界对其功效和安全性存在分歧。